CIBC Private Wealth Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$80M Sell
1,012,699
-6,751
-0.7% -$529K 0.14% 147
2025
Q3
$81.5M Sell
1,019,450
-1,136
-0.1% -$96.9K 0.14% 152
2025
Q2
$92.8M Sell
1,020,586
-2,192
-0.2% -$200K 0.17% 137
2025
Q1
$90.6M Sell
1,022,778
-7,087
-0.7% -$635K 0.19% 121
2024
Q4
$90.1M Buy
1,029,865
+561
+0.1% +$53.5K 0.16% 131
2024
Q3
$107M Buy
1,029,304
+303,194
+42% +$30.9M 0.19% 117
2024
Q2
$70.9M Buy
726,110
+181,308
+33% +$16.7M 0.13% 144
2024
Q1
$48.5M Buy
544,802
+134,745
+33% +$11.4M 0.1% 182
2023
Q4
$32.7M Sell
410,057
-3,114
-0.8% -$234K 0.07% 217
2023
Q3
$29.4M Sell
413,171
-184,368
-31% -$13.8M 0.07% 219
2023
Q2
$46M Sell
597,539
-4,495
-0.7% -$348K 0.1% 171
2023
Q1
$45.2M Buy
602,034
+81,933
+16% +$6.09M 0.1% 178
2022
Q4
$39.3M Buy
520,101
+241,427
+87% +$18.1M 0.13% 109
2022
Q3
$19.6M Sell
278,674
-2,556
-0.9% -$200K 0.05% 230
2022
Q2
$22.5M Sell
281,230
-687
-0.2% -$53.7K 0.06% 217
2022
Q1
$21.4M Sell
281,917
-32,680
-10% -$2.59M 0.05% 240
2021
Q4
$26.8M Buy
314,597
+35,968
+13% +$2.81M 0.06% 225
2021
Q3
$21.1M Sell
278,629
-8,248
-3% -$655K 0.05% 243
2021
Q2
$23.3M Sell
286,877
-8,733
-3% -$714K 0.05% 233
2021
Q1
$23.3M Sell
295,610
-7,763
-3% -$608K 0.06% 225
2020
Q4
$25.9M Buy
303,373
+7,630
+3% +$631K 0.07% 195
2020
Q3
$22.8M Sell
295,743
-217,915
-42% -$16.6M 0.07% 192
2020
Q2
$37.6M Buy
513,658
+205,772
+67% +$14.6M 0.18% 96
2020
Q1
$20.4M Sell
307,886
-354
-0.1% -$25K 0.09% 166
2019
Q4
$21.2M Buy
308,240
+108,983
+55% +$7.43M 0.07% 198
2019
Q3
$14.6M Sell
199,257
-7,837
-4% -$569K 0.05% 235
2019
Q2
$14.8M Sell
207,094
-17,664
-8% -$1.25M 0.05% 242
2019
Q1
$15.4M Sell
224,758
-136,881
-38% -$8.84M 0.06% 232
2018
Q4
$21.5M Sell
361,639
-851,203
-70% -$53.3M 0.1% 186
2018
Q3
$81.2M Sell
1,212,842
-6,846
-0.6% -$456K 0.31% 97
2018
Q2
$79M Sell
1,219,688
-2,114
-0.2% -$138K 0.32% 95
2018
Q1
$87.6M Buy
1,221,802
+9,245
+0.8% +$665K 0.38% 81
2017
Q4
$91.5M Sell
1,212,557
-19,943
-2% -$1.46M 0.39% 80
2017
Q3
$89.8M Buy
1,232,500
+41,709
+4% +$3.01M 0.41% 73
2017
Q2
$88.3M Sell
1,190,791
-4,670
-0.4% -$347K 0.55% 60
2017
Q1
$87.5M Sell
1,195,461
-437,481
-27% -$30.6M 0.55% 62
2016
Q4
$107M Buy
1,632,942
+452,159
+38% +$31M 0.71% 48
2016
Q3
$87.5M Buy
1,180,783
+11,769
+1% +$870K 0.61% 54
2016
Q2
$85.6M Buy
1,169,014
+9,074
+0.8% +$646K 0.62% 54
2016
Q1
$81.9M Buy
1,159,940
+18,338
+2% +$1.22M 0.63% 54
2015
Q4
$76.1M Sell
1,141,602
-11,067
-1% -$736K 0.6% 57
2015
Q3
$73.1M Buy
1,152,669
+7,777
+0.7% +$508K 0.6% 58
2015
Q2
$74.9M Buy
1,144,892
+4,722
+0.4% +$320K 0.55% 61
2015
Q1
$79.1M Buy
1,140,170
+6,408
+0.6% +$443K 0.58% 59
2014
Q4
$78.4M Buy
1,133,762
+10,929
+1% +$738K 0.6% 53
2014
Q3
$73.2M Buy
1,122,833
+19,064
+2% +$1.26M 0.58% 57
2014
Q2
$75.3M Buy
1,103,769
+11,124
+1% +$746K 0.61% 51
2014
Q1
$70.3M Buy
+1,092,645
New +$68.9M 0.6% 51

Other funds holding CL

CIBC Private Wealth Group's CL Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Colgate-Palmolive (CL) stake by 0.66% in Q4 2025, selling an estimated $529K and leaving 1,012,699 shares worth $80M. The position accounts for 0.14% of the portfolio, ranked #147.

CIBC Private Wealth Group first reported a position in CL in Q1 2014 and has held it in 48 quarters since. The position peaked at $107M in Q4 2016. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • CIBC Private Wealth Group held 1,012,699 shares of Colgate-Palmolive worth $80M as of Q4 2025.
  • CIBC Private Wealth Group sold 6,751 Colgate-Palmolive shares in Q4 2025, an estimated $529K.
  • Colgate-Palmolive made up 0.14% of CIBC Private Wealth Group's portfolio in Q4 2025, its #147 holding.
  • CIBC Private Wealth Group first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 48 quarters since.
  • CIBC Private Wealth Group's Colgate-Palmolive position peaked at $107M in Q4 2016.
  • 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.